S. Troyanov

发表

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

Fernand, V. D’Agati, C. Alpers, 2009, Kidney international.

Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.

V. D’Agati, C. Alpers, B. Julian, 2017, Kidney international.

Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.

Vladimir Tesar, John Feehally, R. Coppo, 2015, Journal of the American Society of Nephrology : JASN.

Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.

Hong Zhang, J. Lv, D. Cattran, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients.

Jian-ming Wang, Hongbing Shen, S. Phillips, 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Validation of the Oxford classification of IgA nephropathy.

B. Julian, D. Cattran, H. Reich, 2011, Kidney international.

Validating the oxford classification of IgA nephropathy.

F. Fervenza, S. Troyanov, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Response to ‘Nomenclature of the Oxford classification of IgA nephropathy: do we need to be careful?’

R. Coppo, J. Feehally, D. Cattran, 2010 .

The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults.

V. D’Agati, C. Alpers, B. Julian, 2010, Kidney international.

On behalf of the Working Group of the International IgA Nephropathy Network & Renal Pathology Society

R. Camilla, R. Coppo, J. Feehally, 2010 .

The impact of sex in primary glomerulonephritis.

H. Beanlands, J. Scholey, D. Cattran, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Remission of proteinuria improves prognosis in IgA nephropathy.

J. Scholey, D. Cattran, H. Reich, 2007, Journal of the American Society of Nephrology : JASN.

Gene Polymorphisms as Clinical Tools in Chronic Glomerulopathies: A Prospective Study

Isabelle Chapdelaine, F. Madoré, S. Troyanov, 2013, Nephron Clinical Practice.

The new Oxford Clinico-Pathological Classification of IgA nephropathy.

R. Camilla, R. Coppo, J. Feehally, 2010, Prilozi.

Formulas for Calculated Osmolarity and Osmolal Gap: A Study of Diagnostic Accuracy.

J. Bouchard, F. Madoré, M. Ghannoum, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The natural history of the non-nephrotic membranous nephropathy patient.

D. Cattran, S. Troyanov, M. Hladunewich, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

L. Morando, R. Camilla, G. Mazzucco, 2014, Kidney international.

Clinical Use of Complement, Inflammation, and Fibrosis Biomarkers in Autoimmune Glomerulonephritis

A. Bonnefoy, S. Troyanov, J. Rioux, 2020, Kidney international reports.

Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.

J. Scholey, D. Cattran, Judith A. Miller, 2005, Journal of the American Society of Nephrology : JASN.

Idiopathic membranous nephropathy: definition and relevance of a partial remission.

J. Scholey, D. Cattran, Judith A. Miller, 2004, Kidney international.

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.

Sandrine Florquin, Mark Haas, Hong Zhang, 2009, Kidney international.

Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy

M. Leblanc, M. Ghannoum, S. Troyanov, 2004, Intensive Care Medicine.

Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy

A. Bonnefoy, F. Madoré, V. Pichette, 2019, Kidney international reports.

Impact of updated recommendations on acetylsalicylic acid use for primary prevention of cardiovascular disease in Canada: a population-based survey.

J. Bouchard, F. Madoré, J. Guertin, 2020, CMAJ open.

How Should Pathology Findings Influence Treatment in IgA Nephropathy?

H. Reich, S. Troyanov, M. Hladunewich, 2021, Kidney international reports.

Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.

P. McFarlane, B. Manns, S. Soroka, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing

A. Bonnefoy, C. Merlen, G. Rivard, 2022, Orphanet Journal of Rare Diseases.

Frequency and determinants of exaggerated bronchoconstriction during shortened methacholine challenge tests in epidemiological and clinical set-ups.

J. Malo, A. Cartier, D. Gautrin, 2000, The European respiratory journal.

Comparison of circadian variations using FEV1 and peak expiratory flow rates among normal and asthmatic subjects.

J. Malo, H. Ghezzo, A. Cartier, 1994, Thorax.

Persistent Mixed Cryoglobulinemia Despite Successful Treatment of Hepatitis C, Aggressive B-Cell–Directed Therapies, and Long-term Plasma Exchanges

V. Royal, K. Jao, S. Troyanov, 2019, Kidney international reports.

Risk Factors and Timing of Native Kidney Biopsy Complications

L. Roy, Soumeya Brachemi, S. Troyanov, 2014, Nephron Extra.

Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using Multiflow-100 and HF1000 filters.

Daniel Parent, M. Leblanc, S. Troyanov, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Activated Alpha 2-Macroglobulin Is a Novel Mediator of Mesangial Cell Profibrotic Signaling in Diabetic Kidney Disease

S. Pizzo, J. Krepinsky, M. Inman, 2021, Biomedicines.

Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients.

I. Sirois, N. Vigneault, F. Madoré, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Notice

Jai Radhakrishnan, Jürgen Floege, Brad H. Rovin, 2012, Kidney International Supplements.

Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.

R. Camilla, F. Madoré, Tara Macrae, 2011, Journal of nephrology.

Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis

A. Bonnefoy, C. Merlen, Anne-Laure Lapeyraque, 2022, Kidney international reports.

Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study.

J. Bouchard, F. Madoré, J. Verhave, 2013, Diabetes research and clinical practice.

Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis

A. Frenette, D. Williamson, J. Bouchard, 2014, Critical Care.

Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy

R. Camilla, L. Peruzzi, R. Coppo, 2015, Nephron.

Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study

J. Bouchard, V. Pichette, V. Lavergne, 2015, Nephron.

A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy.

Su-xia Wang, C. Alpers, R. Coppo, 2017, Journal of the American Society of Nephrology : JASN.

Meta-GWAS Reveals Novel Genetic Variants Associated with Urinary Excretion of Uromodulin

M. P. Concas, I. Deary, S. Bergmann, 2022, Journal of the American Society of Nephrology : JASN.

Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: A multicenter retrospective study.

A. Pani, B. Knebelmann, S. Nasr, 2020, Blood.

Continuous venovenous hemofiltration using customized replacement fluid for acute kidney injury with severe hypernatremia

J. Bouchard, F. Madoré, S. Troyanov, 2016, Clinical kidney journal.

Clinical, Genetic, and Urinary Factors Associated with Uromodulin Excretion.

P. Awadalla, O. Devuyst, Sonia Youhanna, 2016, Clinical journal of the American Society of Nephrology : CJASN.

Successful hemodialysis in a phenytoin overdose: case report and review of the literature.

V. Lavergne, M. Ghannoum, S. Troyanov, 2010, Clinical nephrology.

Carbamazepine poisoning treated by multiple extracorporeal treatments.

J. Bouchard, F. Madoré, M. Ghannoum, 2015, Clinical nephrology.

Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease.

I. Sirois, N. Vigneault, F. Madoré, 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renal pathology in idiopathic membranous nephropathy: a new perspective.

D. Cattran, S. Troyanov, A. Herzenberg, 2006, Kidney international.

Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort.

S. Bellur, I. Roberts, H. Cook, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapy.

D. Cattran, S. Kim, H. Reich, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Lymphopenia and treatment-related infectious complications in ANCA-associated vasculitis.

C. Déziel, Y. Troyanov, Soumeya Brachemi, 2013, Clinical journal of the American Society of Nephrology : CJASN.

Increased urinary excretion of hedgehog interacting protein (uHhip) in early diabetic kidney disease.

J. Ingelfinger, J. Cailhier, Shiao-Ying Chang, 2019, Translational research : the journal of laboratory and clinical medicine.

Soluble Fas: a novel predictor of atherosclerosis in dialysis patients.

I. Sirois, N. Vigneault, F. Madoré, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Prevalence, awareness, and management of CKD and cardiovascular risk factors in publicly funded health care.

P. Awadalla, J. Bouchard, F. Madoré, 2014, Clinical journal of the American Society of Nephrology : CJASN.

Central blood pressures in early chronic kidney disease: an analysis of CARTaGENE

P. Hamet, F. Madoré, S. Troyanov, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Heart rate dependent and independent effects of beta-blockers on central hemodynamic parameters: a propensity score analysis

F. Madoré, S. Troyanov, M. Agharazii, 2016, Journal of hypertension.

Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery*

F. Madoré, S. Troyanov, Patrick Roy, 2009, Critical care medicine.

Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.

B. Julian, J. Novak, R. Camilla, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis

J. A. Miller, D. Naimark, Z. Harel, 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Estimating the Change in Renal Function During the First Year of Therapy in ANCA-Associated Vasculitis

L. Laurin, F. Gougeon, M. Rhéaume, 2019, Kidney international reports.

Uric acid association with pulsatile and steady components of central and peripheral blood pressures

F. Madoré, S. Troyanov, F. Lepeytre, 2017, Journal of hypertension.

Diagnosis and outcomes of acute kidney injury using surrogate and imputation methods for missing preadmission creatinine values

W. Beaubien-Souligny, J. Bouchard, F. Madoré, 2017, BMC Nephrology.

Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.

Ingeborg Bajema, Konstantinos Giannakakis, Hermann-Josef Gröne, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Uromodulin in a Pathway Between Decreased Renal Urate Excretion and Albuminuria

P. Awadalla, R. Cífková, P. Hamet, 2018, American journal of hypertension.

Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.

R. Coppo, V. Tesar, J. Feehally, 2015, Journal of the American Society of Nephrology : JASN.

The natural history of the non-nephrotic membranous nephropathy patient.

D. Cattran, S. Troyanov, M. Hladunewich, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Clinical, Genetic, and Urinary Factors Associated with Uromodulin Excretion.

P. Awadalla, O. Devuyst, Sonia Youhanna, 2016, Clinical journal of the American Society of Nephrology : CJASN.

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

V. D’Agati, C. Alpers, B. Julian, 2009, Kidney international.

Obinutuzumab Rescue in Rituximab Resistant Mixed Cryoglobulinemia

G. Faucher, S. Troyanov, D. Genest, 2021, Kidney international reports.

Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.

S. Bellur, S. Troyanov, Rosanna Coppo, 2024, Kidney international.

Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort.

S. Bellur, I. Roberts, H. Cook, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease.

C. Merlen, Anne-Laure Lapeyraque, Soumeya Brachemi, 2023, Kidney international reports.

Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse

J. Scholey, H. Reich, J. Goldstein, 2023, Kidney international reports.

Have we changed the outcome in membranous nephropathy? A propensity study on the role of immunosuppressive therapy.

H. Reich, S. Troyanov, D. C. Cattran, 2011, Clinical journal of the American Society of Nephrology : CJASN.